Cargando…

Circular RNA as a Novel Biomarker and Therapeutic Target for HCC

Circular RNA (circRNA) is a kind of endogenous non-coding RNA (ncRNA), which is produced by the reverse splicing of precursor mRNA (pre mRNA). It is widely expressed in a variety of biological cells. Due to the special formation mode, circRNA does not have a 5′ terminal cap and 3′ poly (A) tail stru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Hongwu, Niu, Ruowen, Huang, Cheng, Li, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222032/ https://www.ncbi.nlm.nih.gov/pubmed/35741077 http://dx.doi.org/10.3390/cells11121948

Ejemplares similares

Circular RNA: a novel biomarker and therapeutic target for human cancers
por: Lei, Bo, et al.
Publicado: (2019)

Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers
por: Zhou, Meng, et al.
Publicado: (2020)

Prospect of Circular RNA in Hepatocellular Carcinoma: A Novel Potential Biomarker and Therapeutic Target
por: Yao, Renzhi, et al.
Publicado: (2018)

Circular RNAs as Novel Diagnostic Biomarkers and Therapeutic Targets in Kidney Disease
por: Yu, Jianwen, et al.
Publicado: (2021)

Circular RNAs in Gastric Cancer: Potential Biomarkers and Therapeutic Targets
por: Ouyang, Jiafeng, et al.
Publicado: (2020)

Circular RNAs: Novel Players in the Oxidative Stress-Mediated Pathologies, Biomarkers, and Therapeutic Targets
por: Wang, Yunguang, et al.
Publicado: (2021)

Circular RNA: A novel type of biomarker for glioma
por: Sun, Wei, et al.
Publicado: (2021)

An Overview of Biomarkers and Molecular Signatures in HCC
por: Yim, Seon-Hee, et al.
Publicado: (2010)

DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC
por: Liu, Nanbin, et al.
Publicado: (2023)

Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets
por: Qiu, Yumin, et al.
Publicado: (2022)

Circular RNAs: Potential Applications as Therapeutic Targets and Biomarkers in Breast Cancer
por: Sarkar, Debina, et al.
Publicado: (2021)

Circular RNA as Therapeutic Targets in Atherosclerosis: Are We Running in Circles?
por: Triska, Jeffrey, et al.
Publicado: (2023)

A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR
por: Song, Runjie, et al.
Publicado: (2023)

Roles of Aging, Circular RNAs, and RNA Editing in the Pathogenesis of Amyotrophic Lateral Sclerosis: Potential Biomarkers and Therapeutic Targets
por: Hosaka, Takashi, et al.
Publicado: (2023)

The Biomarker and Therapeutic Potential of Circular Rnas in Schizophrenia
por: Nedoluzhko, Artem, et al.
Publicado: (2020)

EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC
por: Słomka, Artur, et al.
Publicado: (2020)

Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome
por: Jing, Tianrui, et al.
Publicado: (2023)

Circular RNAs: Novel Promising Biomarkers in Ocular Diseases
por: Guo, Nan, et al.
Publicado: (2019)

Therapeutic Strategies in HCC: Radiation Modalities
por: Gallicchio, R., et al.
Publicado: (2016)

COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC
por: Zhang, Jiayao, et al.
Publicado: (2021)

Circular RNAs in gynecological disease: promising biomarkers and diagnostic targets
por: Huang, Jie, et al.
Publicado: (2019)

Circular RNAs: emerging cancer biomarkers and targets
por: Zhang, Yu, et al.
Publicado: (2017)

Promising Roles of Circular RNAs as Biomarkers and Targets for Potential Diagnosis and Therapy of Tuberculosis
por: Huang, Yifan, et al.
Publicado: (2022)

Novel endogenous angiogenesis inhibitors and their therapeutic potential
por: Rao, Nithya, et al.
Publicado: (2015)

Circular RNA expression profile of lung squamous cell carcinoma: identification of potential biomarkers and therapeutic targets
por: Wang, Yawei, et al.
Publicado: (2020)

Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation
por: Yu, Jian, et al.
Publicado: (2023)

Novel Biomarkers and Therapeutic Targets for Melanoma
por: Sabag, Noa, et al.
Publicado: (2022)

HNRNPM Regulates HCC Tumorigenesis and Cancer Stemness: Identification of a Novel Therapeutic Target?
por: Kennedy, Lindsey
Publicado: (2022)

Circular RNAs: A novel type of biomarker and genetic tools in cancer
por: Han, Yi-Neng, et al.
Publicado: (2017)

Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC
por: Wang, Chun-I, et al.
Publicado: (2021)

Circular RNAs as novel potential biomarkers for pancreatic cancer
por: Liu, Shanshan, et al.
Publicado: (2021)

Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2021)

The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy
por: Ren, Yin-Xiang, et al.
Publicado: (2022)

Circular RNA hsa_circ_0006091 as a novel biomarker for hepatocellular carcinoma
por: Zhang, Yongwei, et al.
Publicado: (2022)

In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
por: Ding, Bisha, et al.
Publicado: (2019)

Circular RNA cIARS regulates ferroptosis in HCC cells through interacting with RNA binding protein ALKBH5
por: Liu, Zhiqian, et al.
Publicado: (2020)

Circular RNA and its potential as prostate cancer biomarkers
por: Tucker, Dwayne, et al.
Publicado: (2020)

Identification of long non-coding RNA ZFAS1 as a novel biomarker for diagnosis of HCC
por: Luo, Ping, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7hin8kpa9cusf16nr8ftqdg7nn